Open Journal of Ophthalmology
Vol.4 No.1(2014), Paper ID 42836, 7
pages
DOI:10.4236/ojoph.2014.41005
Aqueous Interleukin-6 (IL-6) Level Is a Marker for Treatment Resistance to Bevacizumab in Age-Related Macular Degeneration —Aqueous Cytokines after Bevacizumab
Kakarla V. Chalam, Sandeep Grover, Sankarathi Balaiya, Ravi K. Murthy
Department of Ophthalmology, University of Florida College of Medicine, Jacksonville, USA
Department of Ophthalmology, University of Florida College of Medicine, Jacksonville, USA
Department of Ophthalmology, University of Florida College of Medicine, Jacksonville, USA
Department of Ophthalmology, University of Florida College of Medicine, Jacksonville, USA
Copyright © 2014 Kakarla V. Chalam, Sandeep Grover, Sankarathi Balaiya, Ravi K. Murthy et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Chalam, K. , Grover, S. , Balaiya, S. and Murthy, R. (2014) Aqueous Interleukin-6 (IL-6) Level Is a Marker for Treatment Resistance to Bevacizumab in Age-Related Macular Degeneration —Aqueous Cytokines after Bevacizumab.
Open Journal of Ophthalmology,
4, 24-30. doi:
10.4236/ojoph.2014.41005.